Balloon catheter

Global Balloon Catheter Market Analysis Report 2023-2030: Minimally Invasive Solutions and Age-Associated Cardiovascular Problems Drive Demand - ResearchAndMarkets.com

Retrieved on: 
Friday, March 22, 2024
Medical Supplies, Medical Devices, Health, Surgery, Cardiology, Biotechnology, Coronary artery disease, Balloon catheter, Neurology, Prevalence, Headache, Urbanization, Blood, Peripheral artery disease, Urology, Angioplasty, Nylon, Hospital, Restenosis, Research, Splenic infarction, Telehealth, Heart, Stroke, Artery, Safety, Prognosis, Catheter, FDA, Artificial intelligence, CAD, Ageing, Medical device

The "Global Balloon Catheter Market, Size, Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Balloon Catheter Market, Size, Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report has been added to ResearchAndMarkets.com's offering.
  • The growing prevalence of age-associated cardiovascular problems propels balloon catheter demand, significantly increasing the medical device market and enhancing the care of growing older populations globally.
  • Offering minimally invasive alternatives to conventional surgeries, balloon catheters lead to faster recuperation instances, decreased dangers, and progressed patient effects, driving market increase towards minimally invasive tactics.
  • By product type, the Global Balloon Catheter Market is divided into Normal Balloon Catheter, Drug Eluting Balloon Catheter, Cutting Balloon Catheter, Scoring Balloon Catheter, Stent Graft Balloon Catheter, and Others.

BIOMERICS EXPANDS MANUFACTURING OPERATIONS IN TEXAS

Retrieved on: 
Friday, April 14, 2023
Partnership, CNC, SALT, Engineering, Economic development, Balloon, Growth, Balloon catheter, Amusement park, Drug

ft. expansion of manufacturing operations at their Athens, TX, facility.

Key Points: 
  • ft. expansion of manufacturing operations at their Athens, TX, facility.
  • ft. of production space and the expansion of Biomerics' Center of Excellence for Balloons & Balloon Catheters with a 4,900 sq.
  • I'm thrilled to see our vertical integration on full display in one building," stated Chris Richardson, President of Biomerics Interventional Advanced Catheter.
  • "The new building expansion in Athens Industrial Park is such a great demonstration of our partnership with Biomerics.

BIOMERICS EXPANDS MANUFACTURING OPERATIONS IN TEXAS

Retrieved on: 
Friday, April 14, 2023
Partnership, CNC, SALT, Engineering, Economic development, Balloon, Growth, Balloon catheter, Amusement park, Drug

ft. expansion of manufacturing operations at their Athens, TX, facility.

Key Points: 
  • ft. expansion of manufacturing operations at their Athens, TX, facility.
  • ft. of production space and the expansion of Biomerics' Center of Excellence for Balloons & Balloon Catheters with a 4,900 sq.
  • I'm thrilled to see our vertical integration on full display in one building," stated Chris Richardson, President of Biomerics Interventional Advanced Catheter.
  • "The new building expansion in Athens Industrial Park is such a great demonstration of our partnership with Biomerics.

Global Percutaneous Transluminal Coronary Angioplasty Balloon Catheters Market to 2027 - Featuring Abbott Laboratories, Biotronik, Cardinal Health and Medtronic Among Others - ResearchAndMarkets.com

Retrieved on: 
Thursday, October 27, 2022
Medical Devices, Health, Growth, CAGR, PTCA, Balloon catheter, Percutaneous coronary intervention, Pharmaceutical industry, Pet

The "Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
  • The global market for Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters estimated at US$997.6 Million in the year 2020, is projected to reach a revised size of US$1.3 Billion by 2027, growing at a CAGR of 3.6% over the analysis period 2020-2027.
  • The U.S. Market is Estimated at $271.8 Million, While China is Forecast to Grow at 5.7% CAGR
    The Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters market in the U.S. is estimated at US$271.8 Million in the year 2020.
  • In the global Cutting Balloon Catheter segment, USA, Canada, Japan, China and Europe will drive the 2.8% CAGR estimated for this segment.

Global Balloon Catheter Market Report 2022-2027: Coronary Artery Disease Segment Leads the Market - ResearchAndMarkets.com

Retrieved on: 
Thursday, April 28, 2022
General Health, Health, Medical Devices, Coronary artery disease, WHO, Awareness, World Health Organization, Death, Blood, World Heart Federation, Patient, CVD, Catheter, COVID-19, Balloon catheter, Femoral artery, Prevalence, Circulatory system, Anatomy, Woman, Cardiac catheterization, CAGR, Heart, Trends and Other Diseases, World, Medical tourism, Cholesterol, Diabetes, Moyamoya disease, Conditional sentence, Industry, Radial artery, Atherosclerosis, Cardiovascular disease, Peripheral artery disease, Man, Renewable energy, Pharmaceutical industry, Medical imaging, Health insurance, Growth

The "Global Balloon Catheter Market, Forecast 2022-2027, Industry Trends, Growth, Outlook, Impact of COVID-19, Opportunity Company Analysis" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Balloon Catheter Market, Forecast 2022-2027, Industry Trends, Growth, Outlook, Impact of COVID-19, Opportunity Company Analysis" report has been added to ResearchAndMarkets.com's offering.
  • The balloon catheter is mostly utilized to treat heart-related diseases caused due to diabetes, high blood pressure, specifically coronary heart disease, and high cholesterol levels in the blood.
  • They are frequently used in varied applications like Coronary Artery Disease, Peripheral Vascular Disease, and Neurovascular Diseases that require the balloon to occlude the anatomy.
  • In terms of application, the Balloon Catheter market can be segmented into Coronary Artery Disease, Peripheral Vascular Disease, Neurovascular Diseases, and Others Diseases.

Sectoral Asset Management Makes $9M Investment into Cagent Vascular

Retrieved on: 
Thursday, June 17, 2021
Cardiology, Medical Supplies, Surgery, Health, Medical devices, Hospitals, Technology, Other Technology, Manufactured goods, Angioplasty, Interventional radiology, Balloon catheter, Balloon, Catheter, Serration

Cagent Vascular Inc.1, a developer of next generation angioplasty balloons using proprietary serration technology, announced the investment of $9M by Sectoral Asset Management.

Key Points: 
  • Cagent Vascular Inc.1, a developer of next generation angioplasty balloons using proprietary serration technology, announced the investment of $9M by Sectoral Asset Management.
  • The Serranator PTA Serration Balloon Catheter is an angioplasty device with serrated metal strips embedded on a semi-compliant balloon.
  • Marc-Andre Marcotte, of Sectoral added, We have been very impressed by Cagents achievements thus far and are excited to partner with them.
  • The information contained herein obtained from Cagent Vascular management is believed to be reliable.

Cardiovascular Systems, Inc. Announces U.S. Commercial Launch of JADE Over-the-Wire Non-Compliant Peripheral Balloon Catheters

Retrieved on: 
Tuesday, June 1, 2021
Health, Medical devices, Cardiology, Manufactured goods, Catheters, Interventional radiology, Goods economics), Balloon catheter, Stent, Balloon, Toy balloon, Peripheral Artery Disease (PAD), Cardiovascular Systems, Inc., OrbusNeich, PERIPHERAL ARTERY DISEASE (PAD), CARDIOVASCULAR SYSTEMS, INC., ORBUSNEICH

JADE is an OTW balloon catheter for PTA in the peripheral vasculature, including obstructed native arteries and synthetic arteriovenous dialysis fistulae, as well as for post-dilatation of balloon expandable and self-expanding stents.

Key Points: 
  • JADE is an OTW balloon catheter for PTA in the peripheral vasculature, including obstructed native arteries and synthetic arteriovenous dialysis fistulae, as well as for post-dilatation of balloon expandable and self-expanding stents.
  • JADE is a non-compliant balloon designed for high pressure tolerance and balloon dilatation with even pressure distribution for the treatment of complex lesions.
  • The predictable, uniform inflation of these non-compliant balloons allows for accuracy in balloon sizing and reduces the potential for vessel recoil.
  • Said Dr. Rao, The deliverability of the JADE balloons, whether it be on the 0.014, 0.018 or 0.035 platform, is exceptional.

Keystone Heart Ltd. and InterValve Medical Inc. enter distribution agreement for balloon aortic valvuloplasty portfolio

Retrieved on: 
Thursday, March 25, 2021
Cardiac surgery, Aortic valvuloplasty, Keystone, Medtech, Balloon catheter

TAMPA, Fla., March 25, 2021 /PRNewswire/ --Keystone Heart, Ltd., a medical device innovator driven to redefine the standard of structural heart care, today announced an exclusive distribution agreement with InterValve Medical Inc. to sell and market their portfolio of balloon aortic valvuloplasty products, in the United States.

Key Points: 
  • TAMPA, Fla., March 25, 2021 /PRNewswire/ --Keystone Heart, Ltd., a medical device innovator driven to redefine the standard of structural heart care, today announced an exclusive distribution agreement with InterValve Medical Inc. to sell and market their portfolio of balloon aortic valvuloplasty products, in the United States.
  • Keystone Heart Ltd. General Manager Steve Sandweg sees the distribution agreement as a unique opportunity to build upon Keystone Heart's structural heart offering.
  • Under the agreement, Keystone Heart Ltd. will begin selling the V8 and TAV8 aortic valvuloplasty balloon catheters in the US market, effective March 25, 2021.
  • Keystone Heart, a Venus Medtech company, is a structural heart medical device company that develops and manufactures total package solutions for structural heart procedures.

Cardiovascular Systems, Inc. Announces Acquisition of Peripheral Support Catheters From WavePoint Medical, LLC

Retrieved on: 
Monday, March 22, 2021
Biotechnology, Surgery, Medical devices, Health, Cardiology, Catheters, Medical specialties, Medicine, Interventional radiology, Clinical medicine, Peripheral artery disease, Balloon catheter, Atherectomy, Cordis, WavePoint Medical, LLC, Cardiovascular Systems, Inc., Coronary Artery Disease (CAD), Peripheral Artery Disease (PAD)

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) announced today that it has acquired a line of peripheral support catheters from WavePoint Medical, LLC.

Key Points: 
  • Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) announced today that it has acquired a line of peripheral support catheters from WavePoint Medical, LLC.
  • Peripheral support catheters are used during peripheral vascular intervention (PVI) procedures for guidewire support to enable lesion crossing, as well as for guidewire exchanges.
  • Scott R. Ward, Chairman, President and Chief Executive Officer of CSI, said, With the acquisition of these peripheral support catheters, CSI will soon offer a complete portfolio of products for the treatment of peripheral artery disease, including atherectomy, balloon catheters, guidewires, support catheters and embolic protection.
  • WavePoint Medical LLC, a MedVenture Holdings portfolio company, is a Utah based medical device development company focused on high-performance micro-catheters for the interventional cardiovascular markets.

India Interventional Cardiology Market Outlook to 2025 - Cardiac Catheters, Coronary Guidewires, Coronary Stents - ResearchAndMarkets.com

Retrieved on: 
Monday, January 25, 2021
Health, Medical Supplies, Cardiology, Medical devices, Medicine, Clinical medicine, Medical equipment, Intravascular ultrasound, Medical ultrasonography, Interventional cardiology, Coronary stent, Cardiac catheterization, Balloon catheter, Cardiology, Cordis, Corindus Vascular Robotics

The "India Interventional Cardiology Market Outlook to 2025 - Cardiac Catheters, Coronary Guidewires, Coronary Stents and Others" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "India Interventional Cardiology Market Outlook to 2025 - Cardiac Catheters, Coronary Guidewires, Coronary Stents and Others" report has been added to ResearchAndMarkets.com's offering.
  • "India Interventional Cardiology Market Outlook to 2025" is a comprehensive databook report, covering key market data on the India Interventional Cardiology market.
  • The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS) and PTCA Balloon Catheters.
  • Global corporate-level profiles of key companies operating within the India Interventional Cardiology Market.